Zydus Lifesciences Limited (ZYDUSLIFE.NS)
INR 831.55
(1.15%)
INR 831.55
(1.15%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 125.21 Billion INR | 6.99% |
| 2022 | 77.14 Billion INR | 18.11% |
| 2021 | 65.32 Billion INR | -2.73% |
| 2020 | 67.15 Billion INR | 1.65% |
| 2019 | 66.05 Billion INR | 20.64% |
| 2018 | 54.75 Billion INR | 10.48% |
| 2017 | 49.56 Billion INR | 16.42% |
| 2016 | 42.57 Billion INR | -0.83% |
| 2015 | 42.93 Billion INR | 11.43% |
| 2014 | 38.52 Billion INR | 13.57% |
| 2013 | 33.92 Billion INR | 13.15% |
| 2012 | 29.98 Billion INR | 23.3% |
| 2011 | 24.31 Billion INR | 17.08% |
| 2010 | 20.76 Billion INR | 14.25% |
| 2009 | 18.17 Billion INR | 30.65% |
| 2008 | 13.91 Billion INR | 25.14% |
| 2007 | 11.11 Billion INR | 30.49% |
| 2006 | 8.52 Billion INR | 50.36% |
| 2005 | 5.66 Billion INR | -0.79% |
| 2004 | 5.71 Billion INR | 11.91% |
| 2003 | 5.1 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 16.28 Billion INR | -30.25% |
| 2023 Q1 | 20.25 Billion INR | -14.3% |
| 2023 FY | 82.54 Billion INR | 6.99% |
| 2023 Q2 | 19.05 Billion INR | -5.96% |
| 2023 Q3 | 19.88 Billion INR | 4.36% |
| 2023 Q4 | 23.35 Billion INR | 17.44% |
| 2022 Q1 | 17.61 Billion INR | 18.75% |
| 2022 FY | 77.14 Billion INR | 18.11% |
| 2022 Q2 | 17.14 Billion INR | -2.65% |
| 2022 Q3 | 18.75 Billion INR | 9.35% |
| 2022 Q4 | 23.63 Billion INR | 26.07% |
| 2021 Q2 | 16.28 Billion INR | -9.13% |
| 2021 Q4 | 14.83 Billion INR | -8.88% |
| 2021 FY | 65.32 Billion INR | -2.73% |
| 2021 Q1 | 17.92 Billion INR | 22.3% |
| 2021 Q3 | 16.27 Billion INR | -0.06% |
| 2020 Q3 | 18.33 Billion INR | 4.45% |
| 2020 Q1 | 17.51 Billion INR | 46.16% |
| 2020 Q4 | 14.65 Billion INR | -20.08% |
| 2020 FY | 67.15 Billion INR | 1.65% |
| 2020 Q2 | 17.55 Billion INR | 0.26% |
| 2019 Q4 | 11.98 Billion INR | -36.1% |
| 2019 FY | 66.05 Billion INR | 20.64% |
| 2019 Q1 | 17.76 Billion INR | 61.02% |
| 2019 Q3 | 18.74 Billion INR | 6.71% |
| 2019 Q2 | 17.56 Billion INR | -1.1% |
| 2018 Q3 | 15.39 Billion INR | 7.73% |
| 2018 Q1 | 14.03 Billion INR | -2.54% |
| 2018 FY | 54.75 Billion INR | 10.48% |
| 2018 Q4 | 11.03 Billion INR | -28.34% |
| 2018 Q2 | 14.29 Billion INR | 1.79% |
| 2017 Q2 | 14.02 Billion INR | 15.69% |
| 2017 FY | 49.56 Billion INR | 16.42% |
| 2017 Q4 | 14.4 Billion INR | -0.04% |
| 2017 Q3 | 14.41 Billion INR | 2.72% |
| 2017 Q1 | 12.12 Billion INR | 0.99% |
| 2016 FY | 42.57 Billion INR | -0.83% |
| 2016 Q1 | 10.58 Billion INR | -2.26% |
| 2016 Q2 | 10.56 Billion INR | -0.13% |
| 2016 Q3 | 10.8 Billion INR | 2.26% |
| 2016 Q4 | 12 Billion INR | 11.11% |
| 2015 FY | 42.93 Billion INR | 11.43% |
| 2015 Q4 | 10.82 Billion INR | -1.72% |
| 2015 Q3 | 11.01 Billion INR | 1.89% |
| 2015 Q2 | 10.81 Billion INR | -2.07% |
| 2015 Q1 | 11.03 Billion INR | 14.13% |
| 2014 Q3 | 10.43 Billion INR | 13.02% |
| 2014 Q2 | 9.23 Billion INR | 0.61% |
| 2014 Q1 | 9.17 Billion INR | 14.24% |
| 2014 FY | 38.52 Billion INR | 13.57% |
| 2014 Q4 | 9.67 Billion INR | -7.34% |
| 2013 Q2 | 8.49 Billion INR | 0.43% |
| 2013 Q1 | 8.45 Billion INR | 45.57% |
| 2013 Q3 | 8.92 Billion INR | 5.1% |
| 2013 Q4 | 8.03 Billion INR | -10.0% |
| 2013 FY | 33.92 Billion INR | 13.15% |
| 2012 Q4 | 5.81 Billion INR | -32.49% |
| 2012 Q3 | 8.6 Billion INR | 9.08% |
| 2012 Q1 | 7.31 Billion INR | 61.47% |
| 2012 FY | 29.98 Billion INR | 23.3% |
| 2012 Q2 | 7.89 Billion INR | 7.86% |
| 2011 Q2 | 6.46 Billion INR | 0.0% |
| 2011 Q4 | 4.53 Billion INR | -36.73% |
| 2011 Q3 | 7.16 Billion INR | 10.81% |
| 2011 FY | 24.31 Billion INR | 17.08% |
| 2010 FY | 20.76 Billion INR | 14.25% |
| 2009 FY | 18.17 Billion INR | 30.65% |
| 2008 FY | 13.91 Billion INR | 25.14% |
| 2007 FY | 11.11 Billion INR | 30.49% |
| 2006 FY | 8.52 Billion INR | 50.36% |
| 2005 FY | 5.66 Billion INR | -0.79% |
| 2004 FY | 5.71 Billion INR | 11.91% |
| 2003 FY | 5.1 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Hester Biosciences Limited | 908.84 Million INR | -13677.012% |
| Albert David Limited | 1.02 Billion INR | -12102.053% |
| Alembic Limited | 872.45 Million INR | -14251.522% |
| Alkem Laboratories Limited | 32.83 Billion INR | -281.334% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | -688.994% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -27383.565% |
| Bajaj HealthCare Limited | 985.34 Million INR | -12607.326% |
| FDC Limited | 3.49 Billion INR | -3477.705% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | -975.632% |
| Gufic Biosciences Limited | 1.18 Billion INR | -10452.179% |
| Hikal Limited | 4.46 Billion INR | -2705.032% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -5794.546% |
| Ind-Swift Limited | 946.56 Million INR | -13127.907% |
| Innova Captab Limited | 931.03 Million INR | -13348.654% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -28451.134% |
| Jubilant Pharmova Limited | 14.45 Billion INR | -766.272% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -30259.555% |
| Laurus Labs Limited | 11.9 Billion INR | -951.327% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -11556.361% |
| Lupin Limited | 125.09 Billion INR | -0.092% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -77082.114% |
| Medico Remedies Limited | 59.67 Million INR | -209721.533% |
| Morepen Laboratories Limited | 1.98 Billion INR | -6200.083% |
| Nectar Lifesciences Limited | 932.7 Million INR | -13324.574% |
| Orchid Pharma Limited | 800.77 Million INR | -15536.306% |
| Procter & Gamble Health Limited | 2.99 Billion INR | -4080.11% |
| RPG Life Sciences Limited | 1.63 Billion INR | -7555.824% |
| Solara Active Pharma Sciences Limited | 2.55 Billion INR | -4802.353% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 18.79% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -8825.861% |
| Themis Medicare Limited | 1.12 Billion INR | -11021.977% |
| Unichem Laboratories Limited | 6.72 Billion INR | -1761.633% |
| Vaishali Pharma Limited | 84.02 Million INR | -148909.271% |
| Venus Remedies Limited | 1.91 Billion INR | -6434.052% |
| Wanbury Limited | 978.96 Million INR | -12690.128% |
| Windlas Biotech Limited | 1 Billion INR | -12340.115% |
| ZIM Laboratories Limited | 1.01 Billion INR | -12259.707% |
| Ipca Laboratories Limited | 18.98 Billion INR | -559.436% |
| Aarti Drugs Limited | 1.16 Billion INR | -10624.904% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | -3972.697% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -1835838.416% |
| Brooks Laboratories Limited | 51.18 Million INR | -244548.3% |
| Eris Lifesciences Limited | 4.94 Billion INR | -2433.128% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -5588.823% |
| Sigachi Industries Limited | 579.88 Million INR | -21492.31% |
| Sakar Healthcare Limited | 204.07 Million INR | -61254.181% |
| Aurobindo Pharma Limited | 55.65 Billion INR | -124.965% |
| Divi's Laboratories Limited | 14.17 Billion INR | -783.634% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -4962.098% |
| Mankind Pharma Limited | 29.27 Billion INR | -327.737% |
| Sequent Scientific Limited | 2.9 Billion INR | -4214.928% |
| Neuland Laboratories Limited | 2.92 Billion INR | -4173.783% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | -746.447% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | -166.676% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -5879.407% |
| Wockhardt Limited | 8.48 Billion INR | -1376.545% |
| Bal Pharma Limited | 555.62 Million INR | -22435.123% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | -30.594% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -8722.51% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -214714.3% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -5658.151% |
| Shilpa Medicare Limited | 3.33 Billion INR | -3655.38% |
| Valiant Laboratories Limited | 138.02 Million INR | -90613.546% |
| Ajanta Pharma Limited | 30.46 Billion INR | -311.031% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -880861.092% |
| Granules India Limited | 10.31 Billion INR | -1114.132% |
| Medicamen Biotech Limited | 335.16 Million INR | -37257.795% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -36126.576% |
| Piramal Enterprises Limited | 63.65 Billion INR | -96.709% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | -484.495% |
| NATCO Pharma Limited | 10.05 Billion INR | -1144.89% |
| Suven Life Sciences Limited | 109.75 Million INR | -113987.472% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -271177.84% |
| Strides Pharma Science Limited | 9.16 Billion INR | -1266.589% |
| Indoco Remedies Limited | 12.06 Billion INR | -938.13% |
| Alpa Laboratories Limited | 127.38 Million INR | -98197.221% |
| Lasa Supergenerics Limited | 291.17 Million INR | -42902.122% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | -3969.52% |